Articles with "attenuated influenza" as a keyword



Genome-Wide Codon Reprogramming Enables a Multifactorially Attenuated Influenza Vaccine with Broad Cross-Protection.

Sign Up to like & get
recommendations!
Published in 2025 at "Advanced science"

DOI: 10.1002/advs.202516448

Abstract: Live attenuated influenza vaccines (LAIVs) can elicit broad immunity, but rational attenuation strategies are limited. PR8rp, a prototype influenza A virus with five segments extensively reprogrammed to use the least-preferred synonymous codons is generated, introducing… read more here.

Keywords: protection; attenuated influenza; genome wide; wide codon ... See more keywords
Photo from academic.microsoft.com

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study

Sign Up to like & get
recommendations!
Published in 2018 at "Pharmacoepidemiology and Drug Safety"

DOI: 10.1002/pds.4349

Abstract: To evaluate the safety of live attenuated influenza vaccine (LAIV) in children 2 through 17 years of age. read more here.

Keywords: influenza vaccine; safety live; safety; attenuated influenza ... See more keywords

Amino Acid Substitutions N123D and N149D in Hemagglutinin Molecule Enhance Immunigenicity of Live Attenuated Influenza H7N9 Vaccine Strain in Experiment

Sign Up to like & get
recommendations!
Published in 2019 at "Bulletin of Experimental Biology and Medicine"

DOI: 10.1007/s10517-019-04407-1

Abstract: We compared three cold-adapted live attenuated influenza vaccine strains prepared by reverse genetics methods on the basis of master donor virus A/Leningrad/134/17/57 and influenza H7N9 strains A/Anhui/1/2013 and A/Shanghai/1/2013. Two strains based on A/Anhui/1/2013 differed… read more here.

Keywords: anhui 2013; influenza h7n9; attenuated influenza; live attenuated ... See more keywords

Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.

Sign Up to like & get
recommendations!
Published in 2017 at "Vaccine"

DOI: 10.1016/j.vaccine.2017.01.062

Abstract: BACKGROUND Quadrivalent live attenuated influenza vaccine (Q/LAIV) was licensed in 2012 and replaced trivalent live attenuated influenza vaccine in the United States during the 2013-2014 influenza season. This study assessed the safety of Q/LAIV in… read more here.

Keywords: influenza vaccine; safety; aged 49years; attenuated influenza ... See more keywords

The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.

Sign Up to like & get
recommendations!
Published in 2017 at "Vaccine"

DOI: 10.1016/j.vaccine.2017.10.018

Abstract: The influenza A virus components of the live, attenuated influenza vaccine (LAIV) encode the HA and NA gene segments from a circulating virus strain and the remaining gene segments from the cold-adapted master donor virus,… read more here.

Keywords: attenuated influenza; live attenuated; vaccine; replication ... See more keywords

Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.

Sign Up to like & get
recommendations!
Published in 2018 at "Virology"

DOI: 10.1016/j.virol.2018.07.005

Abstract: Cold adapted influenza virus A/Leningrad/134/17/57 (H2N2) is a reliable master donor virus (Len/17-MDV) for preparing live attenuated influenza vaccines (LAIV). LAIVs are 6:2 reasortants that contain 6 segments of Len/17-MDV and the hemagglutinin (HA) and… read more here.

Keywords: 134 h2n2; leningrad 134; attenuated influenza; cold adapted ... See more keywords

Development of a Stable Liquid Formulation for Live Attenuated Influenza Vaccine.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of pharmaceutical sciences"

DOI: 10.1016/j.xphs.2019.02.017

Abstract: Live attenuated influenza vaccine (LAIV) is considered one of the most effective vaccines and can be manufactured quickly and inexpensively to counter seasonal or pandemic influenza. Lyophilization is widely used in vaccine production. However, it… read more here.

Keywords: liquid formulation; production; attenuated influenza; live attenuated ... See more keywords

Generation of a Live Attenuated Influenza A Vaccine Using Chemical-Triggered Intein.

Sign Up to like & get
recommendations!
Published in 2023 at "ACS synthetic biology"

DOI: 10.1021/acssynbio.3c00020

Abstract: Noticeable morbidity and mortality can be caused by influenza A virus in humans. Conventional live attenuated influenza vaccine (LAIV) is one of the main strategies to control the spread of influenza, but its protective efficacy… read more here.

Keywords: influenza vaccine; attenuated influenza; live attenuated; vaccine using ... See more keywords

Defining the root cause of reduced H1N1 live attenuated influenza vaccine effectiveness: low viral fitness leads to inter-strain competition

Sign Up to like & get
recommendations!
Published in 2021 at "NPJ Vaccines"

DOI: 10.1038/s41541-021-00300-z

Abstract: In the 2013–14 and 2015–16 influenza seasons, reduced vaccine effectiveness (VE) was observed for the H1N1 component of the FluMist quadrivalent live attenuated influenza vaccine (QLAIV) in the USA, leading to loss of Advisory Committee… read more here.

Keywords: qlaiv; vaccine effectiveness; influenza vaccine; attenuated influenza ... See more keywords

Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets

Sign Up to like & get
recommendations!
Published in 2021 at "NPJ Vaccines"

DOI: 10.1038/s41541-021-00320-9

Abstract: Influenza viruses cause annual seasonal epidemics and sporadic pandemics; vaccination is the most effective countermeasure. Intranasal live attenuated influenza vaccines (LAIVs) are needle-free, mimic the natural route of infection, and elicit robust immunity. However, some… read more here.

Keywords: homologous challenge; intranasal powder; attenuated influenza; live attenuated ... See more keywords

Synthetic biology-inspired development of live attenuated influenza vaccines

Sign Up to like & get
recommendations!
Published in 2025 at "NPJ Vaccines"

DOI: 10.1038/s41541-025-01255-1

Abstract: Live attenuated influenza vaccines (LAIVs) provide robust, cross-protective immunity but have traditionally been developed empirically and are associated with safety concerns. Recent advances in rational design enable precise genetic modifications to enhance safety and immunogenicity.… read more here.

Keywords: attenuated influenza; influenza vaccines; biology; live attenuated ... See more keywords